Related Experiment Video
Updated: Jan 22, 2026

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives
Jing-Bo Wang1,2, Xue Huang1,2, Fu-Rong Li3,4
1Translational Medicine Collaborative Innovation Center, The Second Clinical Medical College, Shenzhen People's Hospital, Jinan University, 1017 Dongmen Road North, Shenzhen, 518020, Guangdong, P. R. China.
Abstract:
Lung cancer is the leading cause of cancer mortality worldwide. Dendritic cells (DCs) are the key factors providing protective immunity against lung tumors and clinical trials have proven that DC function is reduced in lung cancer patients. It is evident that the immunoregulatory network may play a key role in the failure of the immune response to terminate tumors. Lung tumors likely employ numerous strategies to suppress DC-based anti-tumor immunity. Here, we summarize the recent advances in our understanding on lung tumor-induced immunosuppression in DCs, which affects the initiation and development of T-cell responses. We also describe which existing measures to restore DC function may be useful for clinical treatment of lung tumors. Furthering our knowledge of how lung cancer cells alter DC function to generate a tumor-supportive environment will be essential in order to guide the design of new immunotherapy strategies for clinical use.
Insights
Lung tumors suppress dendritic cell (DC) function, hindering anti-tumor immunity. Restoring DC function offers potential for new lung cancer immunotherapies.
Area of Science:
- Immunology
- Oncology
Background:
- Lung cancer is a leading cause of cancer mortality globally.
- Dendritic cells (DCs) are crucial for anti-tumor immunity, but their function is impaired in lung cancer patients.
- Tumor-induced immunosuppression is a significant barrier to effective anti-cancer immune responses.
Purpose of the Study:
- To summarize recent advances in understanding lung tumor-induced immunosuppression of DCs.
- To explore strategies for restoring DC function in lung cancer treatment.
- To guide the development of novel immunotherapy strategies.
Main Methods:
- Review of current research on DC function in lung cancer.
- Analysis of mechanisms by which lung tumors suppress DC activity.
- Evaluation of existing and potential therapeutic interventions.
Main Results:
- Lung tumors employ various strategies to suppress DC-mediated anti-tumor immunity.
- Impaired DC function affects T-cell initiation and development.
- Several approaches show promise for restoring DC function.
Conclusions:
- Understanding how lung cancer alters DC function is vital for immunotherapy design.
- Restoring DC function is a promising avenue for clinical lung cancer treatment.
- Further research is needed to optimize immunotherapies targeting the DC-immunosuppressive network.
More Related Videos
12:43Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
Related Concept Videos
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Lung Capacity
Neurons: The Cell Body and the Dendrites